Asterias Biotherapeutics

-$0.005 (-0.53%) As of 8:00 PM UTC today

Why Robinhood?

You can watch AST and buy or sell other stocks, options, and ETFs commission-free!

About AST

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases.

CEO
Brian M. Culley, MBA
Employees
—
Headquarters
Carlsbad, California
Founded
2012

AST Key Statistics

Market cap
92.97M
Price-Earnings ratio
—
Dividend yield
—
Average volume
81.23K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$3.75
52 Week low
$1.20
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure